MDNews - Central Pennsylvania

November 2022

Issue link: https://viewer.e-digitaledition.com/i/1483585

Contents of this Issue

Navigation

Page 13 of 15

The Conversation BY CARI WADE GERVIN RESE ARCH CONTINUES TO SHOW THAT MORE AGGRESSIVE SURGICAL TRE ATMENT IS NOT ALWAYS BE T TER FOR SOME BRE A ST CANCER PATIENTS, YE T MANY PHYSICIANS AND PATIENTS CONTINUE TO OPT FOR THE MA XIMALIST APPROACH. IS CHANGE POSSIBLE? THE R ATE OF radical double mastectomies as a f irst-line treatment for early stage breast cancer has increased dramatically in the past decade, despite findings that people with low-grade breast cancer may be receiving unnecessary surgery. "With improvements in systemic ther- apy, bigger surgery is not better surgery, and bigger surgery is certainly associated with more quality-of-life consequences for patients," says Tari A. King, MD, FSSO, Vice Chair for Multidisciplinary Oncolog y in the Department of Surgery and Chief of the Division of Breast Surgery at Brigham and Women's Hospital Dana-Farber/Brigham Cancer Center and Anne E. Dyson Professor of Surgery in the Field of Women's Cancers at Harvard Medical School. "The term de-es- calation has gotten a lot of attention, but it is really about doing the appropriate amount of surgery and/or radiation and/or systemic therapy in the appropriate patients." WHAT THE RESEARCH SHOWS In a recent issue of npj Breast Cancer, a review of the literature shows that breast ca ncer surg ica l practices desig nated a s " low va lue" a re still common. " It 's c h a l l e n g i n g b e c a u s e a l o t o f t h e t r e a t m e nt n or m s i n br e a s t c a n- c er f r om de c a de s a go a r e s o s o ci a l ly ing ra ined — ever yone k nows a woma n who's had bi latera l ma stectomy," says Sa ra h P. Shubeck , M D, MS , A ssist a nt Professor of Surger y at The Universit y of Chicago Pritzker School of Medicine. " We a lso have this notion a round ca ncer that doing the most means doing the most aggressive thing, a nd that must somehow translate into sur viva l outcome. But what you see across multiple large, randomized control tria ls w ith high-qua lit y data is that if we are better able to match a patient with the inter vention needed, they have the sa me benef it." Around in Breast 1 4

Articles in this issue

Archives of this issue

view archives of MDNews - Central Pennsylvania - November 2022